No Data
No Data
Fairmount Funds Management LLC Acquires New Stake in Inhibikase Therapeutics Inc
12 Health Care Stocks Moving In Monday's After-Market Session
Inhibikase Therapeutics Analyst Ratings
Inhibikase Therapeutics Secures $110M for Drug Development
Steven Cohen's Strategic Acquisition of Inhibikase Therapeutics Shares
H.C. Wainwright Maintains Inhibikase Therapeutics(IKT.US) With Buy Rating, Cuts Target Price to $5
No Data
No Data